ATE424560T1 - Marker für neuromyelitis optica - Google Patents
Marker für neuromyelitis opticaInfo
- Publication number
- ATE424560T1 ATE424560T1 AT04812269T AT04812269T ATE424560T1 AT E424560 T1 ATE424560 T1 AT E424560T1 AT 04812269 T AT04812269 T AT 04812269T AT 04812269 T AT04812269 T AT 04812269T AT E424560 T1 ATE424560 T1 AT E424560T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- neuromyelitis optica
- optica
- neuromyelitis
- nmo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/723,180 US7101679B2 (en) | 2003-11-25 | 2003-11-25 | Marker for neuromyelitis optica |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE424560T1 true ATE424560T1 (de) | 2009-03-15 |
Family
ID=34592190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04812269T ATE424560T1 (de) | 2003-11-25 | 2004-11-24 | Marker für neuromyelitis optica |
Country Status (9)
Country | Link |
---|---|
US (5) | US7101679B2 (de) |
EP (1) | EP1700120B1 (de) |
JP (1) | JP4538464B2 (de) |
CN (1) | CN1910456B (de) |
AT (1) | ATE424560T1 (de) |
DE (1) | DE602004019812D1 (de) |
ES (1) | ES2320006T3 (de) |
IN (1) | IN2014DN05011A (de) |
WO (1) | WO2005051178A2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7101679B2 (en) | 2003-11-25 | 2006-09-05 | Mayo Foundation For Medical Education And Research | Marker for neuromyelitis optica |
US20070093673A1 (en) * | 2005-10-24 | 2007-04-26 | Andre Vachereau | Boron-containing compounds, uses and preparation thereof |
JP4273235B2 (ja) * | 2006-06-01 | 2009-06-03 | 国立大学法人 新潟大学 | アクアポリン4阻害薬 |
WO2009039363A2 (en) * | 2007-09-20 | 2009-03-26 | Mayo Foundation For Medical Education And Research | Neuromyelitis optica autoantibodies as a marker for neoplasia |
JP5117336B2 (ja) * | 2008-09-18 | 2013-01-16 | 国立大学法人 千葉大学 | 多発性硬化症またはnmoの検査マーカーの測定方法 |
US9891219B2 (en) * | 2008-10-10 | 2018-02-13 | Mayo Foundation For Medical Education And Research | Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive |
GR1007341B (el) | 2010-04-21 | 2011-07-05 | ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%), | Διαγνωστικος προσδιορισμος |
US9664687B2 (en) * | 2010-05-13 | 2017-05-30 | Rowan University | Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases |
DE102011011280A1 (de) * | 2011-02-15 | 2012-08-16 | Euroimmun Medizinische Labordiagnostika Ag | Diagnosekit sowie ein Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein von Neuromyelitis-optica-spezifischen Antikörpern |
CA2833785C (en) | 2011-04-21 | 2022-06-07 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for the treatment of neuromyelitis optica |
WO2013010003A1 (en) | 2011-07-12 | 2013-01-17 | University Of Medicine And Dentistry Of New Jersey | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
CA2852469A1 (en) * | 2011-10-21 | 2013-04-25 | The Board Of Regents Of The University Of Texas System | Codon signature for neuromyelitis optica |
US10031139B2 (en) | 2012-03-30 | 2018-07-24 | Konica Minolta, Inc. | Method for detecting biological material |
WO2013177116A1 (en) * | 2012-05-21 | 2013-11-28 | The Regents Of The University Of California | Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis optica |
CN102898513B (zh) * | 2012-10-31 | 2016-03-16 | 徐俊 | ELISpot视神经脊髓炎诊断试剂盒及其应用 |
EP2979094B1 (de) | 2013-03-28 | 2018-08-29 | Protagen AG | Verfahren zur diagnose von neuromyelitis optica |
US20170080063A1 (en) * | 2014-05-19 | 2017-03-23 | The Johns Hopkins University | Highly soluble aquaporin-4 extracellular loop c peptide immunization for treatment of neuromyelitis optica |
US20170130269A1 (en) * | 2014-06-30 | 2017-05-11 | Siemens Healthcare Gmbh | Diagnosis of neuromyelitis optica vs. multiple sclerosis using mirna biomarkers |
CN104698190A (zh) * | 2015-03-16 | 2015-06-10 | 中国人民解放军总医院 | 用于中枢神经系统脱髓鞘疾病的生物诊断标记物 |
US10098935B2 (en) * | 2015-05-01 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Aquaporin tolerizing vaccines and methods of use thereof |
WO2017197293A1 (en) * | 2016-05-13 | 2017-11-16 | C.R. Bard, Inc. | Peripherally inserted central catheter systems, devices, and methods thereof for pediatrics |
CN106318974A (zh) * | 2016-08-29 | 2017-01-11 | 南方医科大学南方医院 | 细胞固定工艺及通过该工艺制备aqp4抗体检测试剂盒 |
KR101977843B1 (ko) | 2017-02-16 | 2019-05-13 | 국립암센터 | 시신경척수염 및 다발성경화증의 선별을 위한 바이오마커 및 이의 이용 |
JP7067800B2 (ja) * | 2017-04-12 | 2022-05-16 | 国立大学法人九州大学 | 神経障害性疼痛マーカー及びその使用 |
KR102089042B1 (ko) * | 2017-05-16 | 2020-03-13 | 서울대학교병원 | 보체불활성화법을 이용한 항-아쿠아포린 4 항체의 개선된 검출 방법 |
CN108998450A (zh) * | 2018-08-08 | 2018-12-14 | 昆明医科大学第附属医院 | 引物、cDNA、载体、AQP4单克隆抗体及制备方法 |
CN110618264A (zh) * | 2019-09-10 | 2019-12-27 | 南方医科大学 | 基于量子点聚苯乙烯微球检测抗aqp4抗体的方法 |
CN111272998A (zh) * | 2020-01-09 | 2020-06-12 | 天津天海新域生物科技有限公司 | 一种同时检测中枢脱髓鞘自身抗体aqp4、mog和mbp的方法 |
CN115232795B (zh) * | 2021-07-22 | 2023-09-19 | 北京和合医学诊断技术股份有限公司 | 稳定表达aqp4-m23蛋白的细胞株及其构建方法、应用 |
CN113358881B (zh) * | 2021-08-10 | 2021-11-30 | 首都医科大学附属北京天坛医院 | 用于nmosd预测或复发监测的生物标志物及其应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US37273A (en) * | 1863-01-06 | Improved canteen | ||
US4708713A (en) * | 1984-11-16 | 1987-11-24 | Anisa Medical, Inc. | Method and system for removing immunosuppressive components from the blood of mammals |
US5258503A (en) * | 1987-09-08 | 1993-11-02 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Autoantibody adsorbent and apparatus for removing autoantibodies using the same |
US5614192A (en) * | 1989-07-19 | 1997-03-25 | Connective Therapeutics, Inc. | T cell receptor peptides as therapeutics for immune-related disease |
US5214136A (en) * | 1990-02-20 | 1993-05-25 | Gilead Sciences, Inc. | Anthraquinone-derivatives oligonucleotides |
US5218105A (en) * | 1990-07-27 | 1993-06-08 | Isis Pharmaceuticals | Polyamine conjugated oligonucleotides |
US5741671A (en) * | 1991-12-12 | 1998-04-21 | The Johns Hopkins University | Isolation cloning and expression of transmembrane water channel aquaporin 1(AQP1) |
US5324638A (en) * | 1992-05-13 | 1994-06-28 | Sloan-Kettering Institute For Cancer Research | Brain transcription factor, nucleic acids encoding same and uses thereof |
DE4227695C1 (de) * | 1992-08-21 | 1993-10-07 | Fresenius Ag | Zentrifuge zum Auftrennen von Blut in seine Bestandteile |
US5676644A (en) | 1995-06-07 | 1997-10-14 | Cobe Laboratories, Inc. | Extracorporeal blood processing methods and apparatus |
AU1059897A (en) * | 1995-11-09 | 1997-05-29 | Trustees Of Boston University | Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector |
CA2352167A1 (en) | 1998-11-25 | 2000-06-08 | Amarillo Biosciences, Inc. | Interferon-alpha mediated upregulation of aquaporin expression |
US20040014087A1 (en) | 1999-06-01 | 2004-01-22 | Incyte Corporation | Molecules for diagnostics and therapeutics |
US6409726B1 (en) * | 1999-11-08 | 2002-06-25 | Alan G. Ellman | Electrosurgical instrument for ear surgery |
US20030072737A1 (en) | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US20040048253A1 (en) | 2001-02-21 | 2004-03-11 | Panzer Scott R. | Molecules for diagnostics and therapeutics |
US7251568B2 (en) | 2001-04-18 | 2007-07-31 | Wyeth | Methods and compositions for regulating bone and cartilage formation |
US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
US20040115629A1 (en) | 2002-01-09 | 2004-06-17 | Panzer Scott R | Molecules for diagnostics and therapeutics |
ATE336808T1 (de) * | 2002-06-22 | 2006-09-15 | Spinner Gmbh Elektrotech | Koaxialer steckverbinder |
US7101679B2 (en) | 2003-11-25 | 2006-09-05 | Mayo Foundation For Medical Education And Research | Marker for neuromyelitis optica |
-
2003
- 2003-11-25 US US10/723,180 patent/US7101679B2/en not_active Expired - Lifetime
-
2004
- 2004-11-24 CN CN2004800408513A patent/CN1910456B/zh active Active
- 2004-11-24 WO PCT/US2004/039710 patent/WO2005051178A2/en active Application Filing
- 2004-11-24 AT AT04812269T patent/ATE424560T1/de not_active IP Right Cessation
- 2004-11-24 IN IN5011DEN2014 patent/IN2014DN05011A/en unknown
- 2004-11-24 JP JP2006541455A patent/JP4538464B2/ja active Active
- 2004-11-24 EP EP04812269A patent/EP1700120B1/de active Active
- 2004-11-24 ES ES04812269T patent/ES2320006T3/es active Active
- 2004-11-24 DE DE602004019812T patent/DE602004019812D1/de active Active
-
2006
- 2006-07-14 US US11/457,685 patent/US7947254B2/en active Active
-
2008
- 2008-04-18 US US12/105,755 patent/US8524508B2/en active Active
-
2012
- 2012-05-14 US US13/470,740 patent/US20120219969A1/en not_active Abandoned
-
2014
- 2014-06-02 US US14/293,105 patent/US20140314796A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IN2014DN05011A (de) | 2015-07-10 |
US20140314796A1 (en) | 2014-10-23 |
ES2320006T3 (es) | 2009-05-18 |
US7947254B2 (en) | 2011-05-24 |
US20080145870A1 (en) | 2008-06-19 |
US20050112116A1 (en) | 2005-05-26 |
EP1700120A4 (de) | 2007-11-14 |
CN1910456B (zh) | 2011-04-13 |
US7101679B2 (en) | 2006-09-05 |
US8524508B2 (en) | 2013-09-03 |
WO2005051178A3 (en) | 2005-12-29 |
US20090143710A1 (en) | 2009-06-04 |
DE602004019812D1 (de) | 2009-04-16 |
JP2007518068A (ja) | 2007-07-05 |
WO2005051178A2 (en) | 2005-06-09 |
US20120219969A1 (en) | 2012-08-30 |
EP1700120B1 (de) | 2009-03-04 |
CN1910456A (zh) | 2007-02-07 |
JP4538464B2 (ja) | 2010-09-08 |
EP1700120A2 (de) | 2006-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE424560T1 (de) | Marker für neuromyelitis optica | |
TNSN08255A1 (en) | Anti-mn antibodies and methods of using same | |
ATE483825T1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
NO20062649L (no) | Biarylsulfonamider og metoder for anvendelse av disse | |
NO20090047L (no) | Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
HK1092841A1 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and /or diabetes | |
ATE414535T1 (de) | Trägerproteine für impfstoffe | |
EP1700096A4 (de) | Nachweis von proteinen und prionen mit veränderter konformation | |
CY1108540T1 (el) | Ταυτοποιηση θεραπευτικων ενωσεων | |
TW200700089A (en) | Recombinant protein comprising starch binding domain and use thereof | |
SE0301650D0 (sv) | Novel compounds | |
ITTO20020117A0 (it) | Apparecchiatura per prove tribologiche. | |
DE60326773D1 (de) | Peptid-deformylase-hemmer | |
NO20033921L (no) | Inhibitor av monoaminopptak | |
AU2003293556A1 (en) | Methods of diagnosing and treating cancer | |
DE60207833D1 (de) | Peptiddeformylase-hemmer | |
ATE548037T1 (de) | Peptid-deformylase-hemmer | |
IS7441A (is) | Peptíðdeformýlasatálmar | |
DE60232650D1 (de) | Peptiddeformylaseinhibitoren | |
ATE346915T1 (de) | Hybrid topoisomerasen und ihre verwendung | |
ATE309984T1 (de) | Peptid-deformylase-hemmer | |
WO2004110243A3 (en) | COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPsc |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |